Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-17-026719
Filing Date
2017-11-16
Accepted
2017-11-16 21:19:14
Documents
2
Period of Report
2017-11-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2886
2 EX-24 DOCUMENT attachment1.htm EX-24 3276
  Complete submission text file 0000899243-17-026719.txt   7774
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01830
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01830 617-517-0730
scPharmaceuticals Inc. (Issuer) CIK: 0001604950 (see all company filings)

EIN.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SCPHARMACEUTICALS, INC. 2400 DISTRICT AVE., SUITE 310 BURLINGTON MA 01830
Business Address C/O SCPHARMACEUTICALS, INC. 2400 DISTRICT AVE., SUITE 310 BURLINGTON MA 01830 617-517-0730
Sun Pharmaceutical Industries, Inc. (Reporting) CIK: 0001721949 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38293 | Film No.: 171209583